Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Iron chelation with deferasirox in two patients with HFE hemochromatosis and chronic anemia.

Acta haematologica - 1 Jan 2011

Nagler Michael, Gregor M, Wuillemin W A

Abstract excerpt

We present 2 patients with hyperferritinemia, increased liver iron and hemochromatosis-associated HFE genotypes. At diagnosis, both patients had chronic anemia that prevented initiation of phlebotomy. Iron chelation with deferasirox proved to be a safe and effective means of substantially lowering ferritin levels.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzoates
Share to Hemochromatosis
Share to Hemochromatosis Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class I

Share to Iron Chelating Agents

Share to Membrane Proteins

Share to Treatment Outcome

Share to Triazoles

Source

Identifiers

PMID: 21659727
DOI: 10.1159/000328039

Genes

HFE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Iron chelation with deferasirox in two patients with HFE hemochromatosis and chronic anemia.PMID 21659727Read ↗

Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.Semantic proximity Read ↗

Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.Semantic proximity Read ↗

Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.Semantic proximity Read ↗

Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomy.Semantic proximity Read ↗

Iron chelators reverse organ damage in type 4B hereditary hemochromatosis: Case reports.Semantic proximity Read ↗

A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation.Semantic proximity Read ↗

Iron chelation with deferasirox in a patient with de-novo ferroportin mutation.Semantic proximity Read ↗

A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.Semantic proximity Read ↗

Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.Semantic proximity Read ↗

Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man.Semantic proximity Read ↗

HFE mutations and iron in hemodialysis patients.Semantic proximity Read ↗

[Non-HFE hemochromatosis: a case report].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.